Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

South Africa's Department of Agriculture announced the launch of its first poultry vaccination programme against highly pathogenic avian influenza, sparking both optimism and scepticism within the ind ...

Georgia’s bald eagles are having an average nesting year – and that’s good news, according to the scientists who study them.

The Arizona Department of Agriculture (AZDA) has confirmed a new detection of H5N1 avian influenza in milk from a Maricopa ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

A CDC advisory has recommended to ban the use of thimerosal in flu shots despite no evidence that it causes any harm.

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

In parallel, Guyana began weekly reporting of surveillance data to the Pan American Health Organization (PAHO)/World Health Organization (WHO) via FluNet and ...